An interventional study of Dark Spot Corrector Group in Hyperpigmentation, Dark Spots and Skin Complexion, sponsored by Dime Beauty Co.. Completed at 1 site in United States. Open to participants aged 50 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.
Sponsored by Dime Beauty Co. · Not applicable, Interventional, and Treatment
This is a single-group, open-label, 90-day clinical study to assess the effectiveness of the Dark Spot Corrector by DIME Beauty on reducing the visibility of dark spots and improving overall complexion in females aged 50-65. Thirty-five participants will apply 2 pumps of the product to their entire face twice daily (morning and night) after cleansing and toning.
Efficacy will be evaluated through subject-specific self-reported questionnaires administered at Baseline, Day 14, Day 30, Day 60, and Day 90, as well as expert skin grading and before-and-after photographs taken at Baseline, Day 30, Day 60, and Day 90. The study will also assess secondary outcomes including changes in skin brightness, smoothness, radiance, and evenness of complexion.
127 studies on the registry are indexed under Hyperpigmentation; 28 are open to participants now.
This study's enrollment of 35 is close to the median of 32 across 113 interventional studies indexed under Hyperpigmentation.
Browse Hyperpigmentation studies →Dime Beauty Co. is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Dietary Supplement: Dark Spot Corrector Group
All 35 participants apply 2 pumps of the Dark Spot Corrector by DIME Beauty to the entire face after cleansing and toning, both morning and night, for 90 days. No comparator arm is included.
Change in dark spot visibility as assessed by self-reported questionnaire
Participant-reported reduction in the visibility of dark spots on the face, measured via subject-specific self-reported questionnaires
Time frame: Baseline, Day 14, Day 30, Day 60, and Day 90
Change in dark spot visibility as assessed by expert skin grading of photographs
Expert-graded evaluation of dark spot visibility using standardized facial photographs (front, left, and right sides)
Time frame: Baseline, Day 30, Day 60, and Day 90
Change in skin brightness
Participant-reported improvement in skin brightness assessed via subject-specific self-reported questionnaires
Time frame: Baseline, Day 14, Day 30, Day 60, and Day 90
Change in skin smoothness
Participant-reported improvement in skin smoothness assessed via subject-specific self-reported questionnaires
Time frame: Baseline, Day 14, Day 30, Day 60, and Day 90
Change in skin radiance
Participant-reported improvement in skin radiance assessed via subject-specific self-reported questionnaires
Time frame: Baseline, Day 14, Day 30, Day 60, and Day 90
Change in evenness of complexion
Participant-reported improvement in evenness of complexion assessed via subject-specific self-reported questionnaires
Time frame: Baseline, Day 14, Day 30, Day 60, and Day 90
Change in skin appearance as assessed by expert skin grading of photographs
Expert-graded evaluation of skin brightness, smoothness, radiance, and complexion evenness using standardized facial photographs
Time frame: Baseline, Day 30, Day 60, and Day 90
Ran from Apr 2024 to primary completion in Jul 2024, 3 months.
Of 27 industry-sponsored interventional studies with no phase under Hyperpigmentation, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 10. This study's 3 months is close to that.
Counting every sponsor, half of 64 studies reached it within 7 months; a quarter within 3 and three quarters within 25.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dime Beauty Co.